{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:11:21Z","timestamp":1785881481816,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00535-020-01730-7","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T21:02:17Z","timestamp":1603400537000},"page":"101-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The influence of familial pancreatic cancer on postoperative outcome in pancreatic cancer: relevance to adjuvant chemotherapy"],"prefix":"10.1007","volume":"56","author":[{"given":"Koji","family":"Tezuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3384-2709","authenticated-orcid":false,"given":"Yukiyasu","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiichi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Ohgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Uesaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"1730_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941\u201353.","journal-title":"Int J Cancer"},{"key":"1730_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10:10\u201327.","journal-title":"World J Oncol"},{"key":"1730_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrclinonc.2013.66","volume":"10","author":"J Werner","year":"2013","unstructured":"Werner J, Combs SE, Springfeld C, et al. Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol. 2013;10:323\u201333.","journal-title":"Nat Rev Clin Oncol"},{"key":"1730_CR4","unstructured":"Howlader N, Noone AM, Krapcho M, et al, editors. SEER Cancer Statistics Review, 1975\u20132017. National Cancer Institute. Bethesda, MD based on November 2019 SEER data submission, posted to the SEER web site, Apr 2020. https:\/\/seer.cancer.gov\/csr\/1975_2017\/. Accessed 25 Apr 2020."},{"key":"1730_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","volume":"388","author":"K Uesaka","year":"2016","unstructured":"Uesaka K, Boku N, Fukutomi A, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet. 2016;388:248\u201357.","journal-title":"Lancet"},{"key":"1730_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/jama.2013.279201","volume":"310","author":"H Oettle","year":"2013","unstructured":"Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310:1473\u201381.","journal-title":"JAMA"},{"key":"1730_CR7","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018;379:2395\u2013406.","journal-title":"N Engl J Med"},{"key":"1730_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/j.seminoncol.2018.12.002","volume":"46","author":"AG Raufi","year":"2019","unstructured":"Raufi AG, Manji GA, Chabot JA, et al. Neoadjuvant treatment for pancreatic cancer. Semin Oncol. 2019;46:19\u201327.","journal-title":"Semin Oncol"},{"key":"1730_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030561","author":"F Motoi","year":"2020","unstructured":"Motoi F, Unno M. Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma. Jpn J Clin Oncol. 2020. https:\/\/doi.org\/10.3390\/ijms20030561.","journal-title":"Jpn J Clin Oncol"},{"key":"1730_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1053\/j.seminoncol.2016.09.002","volume":"43","author":"GM Petersen","year":"2016","unstructured":"Petersen GM. Familial pancreatic cancer. Semin Oncol. 2016;43:548\u201353.","journal-title":"Semin Oncol"},{"key":"1730_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ajg.2014.435","volume":"110","author":"S Syngal","year":"2015","unstructured":"Syngal S, Brand RE, Church JM, et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223\u201362.","journal-title":"Am J Gastroenterol"},{"key":"1730_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00534-013-0611-5","volume":"20","author":"K Wada","year":"2013","unstructured":"Wada K, Takaori K, Traverso LW, et al. Clinical importance of Familial Pancreatic Cancer Registry in Japan: a report from kick-off meeting at International Symposium on Pancreas Cancer 2012. J Hepatobiliary Pancreat Sci. 2013;20:557\u201366.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1730_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030561","author":"A Ohmoto","year":"2019","unstructured":"Ohmoto A, Yachida S, Morizane C. Genomic features and clinical management of patients with hereditary pancreatic cancer syndromes and familial pancreatic cancer. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20030561.","journal-title":"Int J Mol Sci"},{"key":"1730_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10689-019-00125-9","volume":"18","author":"I Mintziras","year":"2019","unstructured":"Mintziras I, Bartsch DK. Progress report: familial pancreatic cancer. Fam Cancer. 2019;18:359\u201362.","journal-title":"Fam Cancer"},{"key":"1730_CR15","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-03-3823","volume":"64","author":"AP Klein","year":"2004","unstructured":"Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 2004;64:2634\u20138.","journal-title":"Cancer Res"},{"key":"1730_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","volume":"69","author":"M Goggins","year":"2020","unstructured":"Goggins M, Overbeek KA, Brand R, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020;69:7\u201317.","journal-title":"Gut"},{"key":"1730_CR17","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1002\/cncr.28863","volume":"120","author":"JL Humphris","year":"2014","unstructured":"Humphris JL, Johns AL, Simpson SH, et al. Clinical and pathologic features of familial pancreatic cancer. Cancer. 2014;120:3669\u201375.","journal-title":"Cancer"},{"key":"1730_CR18","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s11605-011-1417-x","volume":"15","author":"JG Barton","year":"2011","unstructured":"Barton JG, Schnelldorfer T, Lohse CM, et al. Patterns of pancreatic resection differ between patients with familial and sporadic pancreatic cancer. J Gastrointest Surg. 2011;15:836\u201342.","journal-title":"J Gastrointest Surg"},{"key":"1730_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10689-014-9755-y","volume":"14","author":"AL Norris","year":"2015","unstructured":"Norris AL, Roberts NJ, Jones S, et al. Familial and sporadic pancreatic cancer share the same molecular pathogenesis. Fam Cancer. 2015;14:95\u2013103.","journal-title":"Fam Cancer"},{"key":"1730_CR20","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospondarowicz MK, Wittekind C. International Union Against Cancer. TNM classification of Malignant Tumours. 8th ed. Oxford: Wiley-Blackwell; 2017.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"1730_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1245\/s10434-017-6324-2","volume":"25","author":"M Yamada","year":"2018","unstructured":"Yamada M, Sugiura T, Okamura Y, et al. Microscopic venous invasion in pancreatic cancer. Ann Surg Oncol. 2018;25:1043\u201351.","journal-title":"Ann Surg Oncol"},{"key":"1730_CR22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.surg.2013.04.015","volume":"154","author":"T Sugiura","year":"2013","unstructured":"Sugiura T, Uesaka K, Mihara K, et al. Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer. Surgery. 2013;154:1078\u201386.","journal-title":"Surgery"},{"key":"1730_CR23","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1002\/cncr.20700","volume":"101","author":"TA James","year":"2004","unstructured":"James TA, Sheldon DG, Rajput A, et al. Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer. 2004;101:2722\u20136.","journal-title":"Cancer"},{"key":"1730_CR24","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/ijc.20210","volume":"110","author":"DK Bartsch","year":"2004","unstructured":"Bartsch DK, Kress R, Sina-Frey M, et al. Prevalence of familial pancreatic cancer in Germany. Int J Cancer. 2004;110:902\u20136.","journal-title":"Int J Cancer"},{"key":"1730_CR25","doi-asserted-by":"publisher","first-page":"74227","DOI":"10.18632\/oncotarget.12490","volume":"7","author":"E Takai","year":"2016","unstructured":"Takai E, Yachida S, Shimizu K, et al. Germline mutations in Japanese familial pancreatic cancer patients. Oncotarget. 2016;7:74227\u201335.","journal-title":"Oncotarget"},{"key":"1730_CR26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000134272","volume":"8","author":"J Ji","year":"2008","unstructured":"Ji J, Forsti A, Sundquist J, et al. Survival in familial pancreatic cancer. Pancreatology. 2008;8:252\u20136.","journal-title":"Pancreatology"},{"key":"1730_CR27","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s11605-009-0923-6","volume":"13","author":"TP Yeo","year":"2009","unstructured":"Yeo TP, Hruban RH, Brody J, et al. Assessment of \u201cgene-environment\u201d interaction in cases of familial and sporadic pancreatic cancer. J Gastrointest Surg. 2009;13:1487\u201394.","journal-title":"J Gastrointest Surg"},{"key":"1730_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","volume":"6","author":"NJ Roberts","year":"2016","unstructured":"Roberts NJ, Norris AL, Petersen GM, et al. Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer. Cancer Discov. 2016;6:166\u201375.","journal-title":"Cancer Discov"},{"key":"1730_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41416-019-0582-7","volume":"122","author":"MM Wattenberg","year":"2020","unstructured":"Wattenberg MM, Asch D, Yu S, et al. Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation. Br J Cancer. 2020;122:333\u20139.","journal-title":"Br J Cancer"},{"key":"1730_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jamcollsurg.2017.12.021","volume":"226","author":"AB Blair","year":"2018","unstructured":"Blair AB, Groot VP, Gemenetzis G, et al. BRCA1\/BRCA2 germline mutation carriers and sporadic pancreatic ductal adenocarcinoma. J Am Coll Surg. 2018;226:630\u20137.","journal-title":"J Am Coll Surg"},{"key":"1730_CR31","doi-asserted-by":"publisher","first-page":"19817","DOI":"10.18632\/oncotarget.24865","volume":"9","author":"T Kondo","year":"2018","unstructured":"Kondo T, Kanai M, Kou T, et al. Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer. Oncotarget. 2018;9:19817\u201325.","journal-title":"Oncotarget."},{"key":"1730_CR32","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/annonc\/mdn527","volume":"19","author":"A Brandt","year":"2008","unstructured":"Brandt A, Bermejo JL, Sundquist J, et al. Age of onset in familial cancer. Ann Oncol. 2008;19:2084\u20138.","journal-title":"Ann Oncol"},{"key":"1730_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/gut.2005.065045","volume":"55","author":"CD McFaul","year":"2006","unstructured":"McFaul CD, Greenhalf W, Earl J, et al. Anticipation in familial pancreatic cancer. Gut. 2006;55:252\u20138.","journal-title":"Gut"},{"key":"1730_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.pan.2015.04.003","volume":"15","author":"AD Singhi","year":"2015","unstructured":"Singhi AD, Ishida H, Ali SZ, et al. A histomorphologic comparison of familial and sporadic pancreatic cancers. Pancreatology. 2015;15:387\u201391.","journal-title":"Pancreatology"},{"key":"1730_CR35","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1245\/s10434-015-4823-6","volume":"22","author":"MN Mavros","year":"2015","unstructured":"Mavros MN, Xu L, Maqsood H, et al. Perioperative blood transfusion and the prognosis of pancreatic cancer surgery: systematic review and meta-analysis. Ann Surg Oncol. 2015;22:4382\u201391.","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01730-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-020-01730-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01730-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T23:54:55Z","timestamp":1634860495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-020-01730-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1007\/s00535-020-01730-7","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"4 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}